Results of three life-span experimental carcinogenicity and anticarcinogenicity studies on tamoxifen in rats

Annals of the New York Academy of Sciences

Volumn 837, Issue , 1997, Pages 469-512

  Maltoni, Cesare ^a   Minardi, Franco ^b   Pinto, Carmine ^b   Belpoggi, Fiorella ^b   Bua, Luciano ^b  

^a European Ramazzini Foundation of Oncology and Environmental Sciences   (Italy)

^b European Foundation of Oncology and Environmental Sciences B Ramazzini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ANIMAL EXPERIMENT; BREAST TUMOR; CARCINOGENICITY; CONFERENCE PAPER; FEMALE; HYPOPHYSIS ADENOMA; INTRAGASTRIC DRUG ADMINISTRATION; LEYDIG CELL TUMOR; LIFESPAN; LIVER CELL CARCINOMA; MALE; NONHUMAN; PANCREAS ISLET CELL TUMOR; PHEOCHROMOCYTOMA; RAT; UTERUS CANCER;

ANIMALIA;

EID: 0031587504     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb56895.x     Document Type: Conference Paper

References (13)

1. COLE, M. P., C. T. A. JONES & I. D. H. TODD. 1971. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI 46474. Br. J. Cancer 25: 270-275.
2. FURR, B. J. A. & V. C. JORDAN. 1984. The pharmacology and clinical uses of tamoxifen. Pharmacol. & Ther. 25: 127-205.
3. JORDAN, V. C. 1976. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur. J. Cancer 12: 419-424.
4. LUDWIG BREAST CANCER STUDY GROUP. 1984. Randomized trial of chemo-endocrine therapy and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastases. Lancet 1: 1256-1260.
5. SENANAYAKE, F. 1984. Adjuvant hormonal chemotherapy in early breast cancer: Early results from a controlled trial. Lancet 2: 1148-1149.
6. CUMMINGS, F. J., R. GRAY, T. E. DAVIS et al. 1985. Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double blind comparison with placebo. Ann. Intern. Med. 103: 324-329.
7. PALSHOF, T., B. CARSTENSEN, H. T. MOURIDSEN et al. 1985. Adjuvant endocrine therapy in pre- and postmenopausal women with operable breast cancer. Rev. Endocrine Rel. Cancer 17 (Suppl.): 43-50.
8. ROSE, C., S. M. THORPE, K. W. ANDERSEN et al. 1985. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high estrogen receptor values. Lancet 1: 16-19.
9. BREAST CANCER TRIALS COMMITTEE, Scottish cancer trials office. 1987. Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet 2: 171-175.
10. DELOZIER, T., J.-P. JULIEN, P. JURET et al. 1987. Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial. Breast Cancer Res. Treat. 7: 105-110.
11. PRITCHARD, K., J. W. MEAKIN, N. F. BOYD et al. 1987. Adjuvant tamoxifen in postmenopausal women with axillary node positive breast cancer: An update. In Adjuvant Therapy of Cancer. S. E. Salmon, Ed.: 391-400. Grune and Stratum. Orlando, FL.
12. RUTQVIST, I. E., B. CEDERMARK, U. GLAS et al. 1987. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Breast Cancer Res. Treat. 10: 255-266.
13. BIANCO, A. R., C. GALLO, S. MARINELLI et al. 1988. Adjuvant therapy with tamoxifen in operable breast cancer: 10 year results of the Naples (GUN) study. Lancet 2: 1095-1099.